These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7080933)

  • 1. The effects of low molecular weight mucus modifying substances on the appearance of mucin gels in the scanning electron microscope.
    Beeson MF; Parish GR; Brown DT; Marriott C
    Adv Exp Med Biol; 1982; 144():365-8. PubMed ID: 7080933
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of purified mucus glycoprotein gels in the assessment of mucolytic activity.
    Marriott C; Brown DT; Beeson MF
    Biorheology; 1983; 20(1):71-9. PubMed ID: 6871427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mucolytic activity using a purified mucus glycoprotein gel.
    Marriott C; Brown DT; Beeson MF
    Adv Exp Med Biol; 1982; 144():93-5. PubMed ID: 7080945
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus.
    Sheehan JK; Richardson PS; Fung DC; Howard M; Thornton DJ
    Am J Respir Cell Mol Biol; 1995 Dec; 13(6):748-56. PubMed ID: 7576713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new mucotropic agent--in vitro and in vivo evaluation of 2-alpha-thenoylthiopropionylglycine (bronchoplus).
    Davis SS; Cox A; Marriott C; Readman AS; Barrett-Bee K
    Eur J Respir Dis; 1985 Aug; 67(2):94-102. PubMed ID: 4054265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemical pharmacology of mucus.
    Parke DV; Symons AM
    Adv Exp Med Biol; 1977; 89():423-41. PubMed ID: 930732
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemical and enzymatic characteristics of bronchial secretions and their changes during treatment with mucolytic drugs].
    Olivieri D; Bocchino M; Marzo C
    Arch Monaldi; 1974; 29(3-4):283-308. PubMed ID: 4463914
    [No Abstract]   [Full Text] [Related]  

  • 8. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
    Pillai K; Akhter J; Chua TC; Morris DL
    Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucus and mucins.
    Rubin BK
    Otolaryngol Clin North Am; 2010 Feb; 43(1):27-34, vii-viii. PubMed ID: 20172254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of an in vivo model for the evaluation of drugs affecting tracheal mucus.
    Readman AS; Marriott C; Barrett-Bee K
    Adv Exp Med Biol; 1982; 144():419-21. PubMed ID: 7080938
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure and macromolecular properties of mucus glycoproteins.
    Carlstedt I; Sheehan JK
    Monogr Allergy; 1988; 24():16-24. PubMed ID: 3362140
    [No Abstract]   [Full Text] [Related]  

  • 12. Nesosteine: a new mucoregulatory agent.
    Scuri R; Mondani P; Frova C; Fantini L
    Drugs Exp Clin Res; 1986; 12(8):663-70. PubMed ID: 3757762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucus-controlling agents: past and present.
    King M; Rubin BK
    Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of mucin secretion: I. The role of intragranular charge shielding.
    Verdugo P; Deyrup-Olsen I; Aitken M; Villalon M; Johnson D
    J Dent Res; 1987 Feb; 66(2):506-8. PubMed ID: 3476567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In-vitro studies with the secretolytic agent Bisolvon (supplement to preliminary clinico-experimental experiences)].
    Bürgi H
    Praxis; 1965 Nov; 54(45):1327-30. PubMed ID: 5899263
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug effects on visco-elasticity--clinical importance?
    Mossberg B
    Eur J Respir Dis Suppl; 1980; 110():193-4. PubMed ID: 6938382
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of mucins with calcium, H+ ion and albumin.
    Forstner JF; Jabbal I; Findlay BP; Forstner GG
    Mod Probl Paediatr; 1976 Oct 24-27; 19():54-65. PubMed ID: 22809
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bronchial mucus modifiers, antioxidants and antiproteases].
    Polu JM; Chabot F; Wallaert B
    Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
    [No Abstract]   [Full Text] [Related]  

  • 19. Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases.
    Braga PC; Allegra L; Bossi R; Scuri R; Castiglioni CL; Romandini S
    Int J Clin Pharmacol Res; 1987; 7(5):381-400. PubMed ID: 3312046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex structure of human bronchial mucus glycoprotein.
    Slayter HS; Lamblin G; Le Treut A; Galabert C; Houdret N; Degand P; Roussel P
    Eur J Biochem; 1984 Jul; 142(2):209-18. PubMed ID: 6745272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.